Dr. Christina Ruda Seed, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 32 Resort Way, Ellsworth, ME 04605 Phone: 207-664-7770 Fax: 207-664-7723 |
Dr. Susan Ann Parlin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 235 High St, Ellsworth, ME 04605 Phone: 207-412-5200 |
Samuel P Hunkler, MD Family Medicine - Adult Medicine Medicare: Medicare Enrolled Practice Location: 32 Resort Way, Ellsworth, ME 04605 Phone: 207-664-7770 Fax: 207-664-7724 |
Dr. Lucille Jean Poulin, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 32 Resort Way, Ellsworth Family Practice, Ellsworth, ME 04605 Phone: 207-664-7770 Fax: 207-664-7723 |
Starie Lynn Seay, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 32 Resort Way, Ellsworth Family Practice, Ellsworth, ME 04605 Phone: 207-664-7770 Fax: 207-664-7723 |
Dr. Stephen Daniel Ruda, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5304 |
Mr. Martin Gerald Higgins, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 32 Resort Way, Ellsworth, ME 04605 Phone: 207-664-7751 |
Daniel J. Reinke, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5304 Fax: 207-664-5305 |
Iris Savernik, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Medicine, Ellsworth, ME 04605 Phone: 207-664-5314 Fax: 207-664-5373 |
Dr. Kenneth L Senter, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 248 State St., Ellsworth Free Medical Clinic, Ellsworth, ME 04605 Phone: 207-667-7953 |
News Archive
A new study published today reports that a large proportion of the United States would be unable to access primary a stroke centre within one hour by ambulance. Stroke is a leading cause of death and disability and rapid treatment is essential to minimise damage to the brain and reduce the risk of prolonged disability.
Blueprint Medicines today announced the completion of a $25 million Series B financing. The oncology-focused investor, Nextech Invest Ltd., led the round, which also included founding investors Third Rock Ventures and Fidelity Biosciences as well as public investors Biotech Value Fund, L.P., Casdin Capital, LLC and other undisclosed investors.
Autosomal dominant polycystic kidney disease is characterized by progressive development of kidney cysts, as well as abnormalities outside the kidneys, including brain aneurysms or weaknesses in blood vessels in the brain that balloon and fill with blood and may later rupture.
Dr Nakano said: "Many randomised clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
› Verified 3 days ago